| Basics |
| Company: |
Hyperfine, Inc. |
| IPO Date: |
January 28, 2021 |
| Sector: |
HYPR |
| Industry: |
Medical Devices |
| Market Cap: |
$79.78M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.09 | 4.57%
|
| Avg Daily Range (30 D): |
$0.06 | 4.76%
|
| Avg Daily Range (90 D): |
$0.04 | 3.70%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.24M |
| Avg Daily Volume (30 D): |
.39M |
| Avg Daily Volume (90 D): |
.19M |
| Trade Size |
| Avg Trade Size (Sh.): |
251 |
| Avg Trade Size (Sh.) (30 D): |
327 |
| Avg Trade Size (Sh.) (90 D): |
358 |
| Institutional Trades |
| Total Inst.Trades: |
11 |
| Avg Inst. Trade: |
$1.33M |
| Avg Inst. Trade (30 D): |
$3.06M |
| Avg Inst. Trade (90 D): |
$3.06M |
| Avg Inst. Trade Volume: |
.59M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.74M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
530.89K |
|
|
|
|
| News |
Jul 16, 2024 @ 2:00 PM
Hyperfine (HYPR) to Release ACTION PMR Study Data ...
Source: N/A
|
May 28, 2024 @ 12:19 PM
Why You Should Bet on 5 Top-Ranked Stocks With Ris...
Source: Sanghamitra Saha
|
May 13, 2024 @ 9:15 PM
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Tops Reven...
Source: Zacks Equity Research
|
May 13, 2024 @ 8:05 PM
Hyperfine, Inc. Reports First Quarter 2024 Financi...
Source: Hyperfine, Inc.
|
May 6, 2024 @ 2:00 PM
Will Hyperfine, Inc. (HYPR) Report Negative Earnin...
Source: Zacks Equity Research
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-.57
|
$-.14
|
$-.14
|
|
Diluted EPS
|
$-.57
|
$-.14
|
$-.14
|
|
Revenue
|
$ 13.26M
|
$ 3.64M
|
$ 3.63M
|
|
Gross Profit
|
$ 6.1M
|
$ 1.91M
|
$ 1.8M
|
|
Net Income / Loss
|
$ -41.01M
|
$ -10.33M
|
$ -10.16M
|
|
Operating Income / Loss
|
$ -44.09M
|
$ -10.96M
|
$ -10.85M
|
|
Cost of Revenue
|
$ 7.16M
|
$ 1.74M
|
$ 1.83M
|
|
Net Cash Flow
|
$ -39.99M
|
$ -7.83M
|
$ -9.4M
|
|
PE Ratio
|
|
|
|
| Splits |
| Aug 13, 2003:
10:1
|
|
